Healthy adults
Conditions
Interventions
(3 capsules/day for 4 weeks)
Placebo supplement (3 capsules/day for 4 weeks)
Sponsors
Tokai University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy Japanese adults who do not receive any treatments 2) Subjects who are not satisfied with their sleep quality 3) Subjects who habitually consume less amount of alcohol than avg 20 g/day 4) Subjects who can give the latest date of medical checkup
Exclusion criteria
Exclusion criteria: 1) Subjects with heart disease, kidney disease, diabetes and other serious disease 2) Subjects who had serious disease and judge not to be suitable for this study 3) Subjects with risk of allergy regarding to this study 4) Subjects who have irregular life style 5) Subjects who cannot stop the use of medicines, herbal medicines and health foods which may affect sleep quality 6) Subjects who cannot take interventional foods following instructions and write life diary 7) Subjects who are in other clinical trials, or participated in other clinical trials within 2 months 8) Subjects who are judged unsuitable for this study by principal investigator and doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep questionnaire(Oguri-Shirakawa-Azumi sleep questionnaire, The St. Mary's Hospital sleep questionnaire, VAS) before and 1, 2, 4 weeks after the intervention with "sulforaphane" or placebo. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep monitoring by wearable devices, Autonomic nervous function tests, Salivary markers(Humoral factor), Physical parameters | — |
Countries
Japan
Contacts
Public ContactNoriaki Kishimoto
Tokai University School of Medicine Dept. of Clinical Health Science
Outcome results
None listed